IP Library Granted Patent US 9,345,473
Granted Patent B2
US 9,345,473 · App. 13/520,125 · Granted May 24, 2016

Implantable sling systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,345,473
App. No.
13/520,125
Granted
May 24, 2016
Kind
B2
Abstract

Various embodiments of sling or implant systems are provided. The sling or implant systems can be employed to treat incontinence, prolapse, and like conditions. A needle delivery device can be included, wherein the delivery device includes a needle and a rotatable sheath. The rotatable sheath can rotate upon actuation relative to the needle to selectively deploy or disengage an implant anchor from the distal end of the needle.

Claims (28)

1. A sling implant system for treating a pelvic condition, comprising:

a sling implant having a support portion and one or more end anchors;

a needle delivery device having a handle body and a needle, wherein the needle includes a distal end portion adapted for selective engagement with the one or more end anchors of the sling implant;

an elongate sheath having a proximal end and a distal end, and adapted to at least partially shroud a length of the needle, with the proximal end housed within the handle body; and

an actuation mechanism having an actuator and at least one cam mechanism housed within the handle body and in operable communication with the elongate sheath, with the actuator including a barrel portion moveable in and out of the handle body such that activation of the actuator operably rotates the sheath about the needle such that the sheath does not move distally, such that the distal end of the elongate sheath rotatably abuts the one or more anchors to deploy the one or more anchors from the distal end portion.

2. The system of claim 1 , wherein the one or more end anchors include an end anchor on each end of the sling implant.

3. The system of claim 1 , wherein the one or more end anchors include extending anchor tines.

4. The system of claim 3 , wherein the elongate sheath includes a barb guard adapted to abut against the extending anchor tines.

5. The system of claim 1 , wherein the elongate sheath includes an angled end surface adapted to engage with the one or more anchors such that rotation of the elongate sheath forces the one or more anchors from the distal end portion of the needle.

6. The system of claim 1 , wherein the actuator is a pushable button in operable communication with the at least one cam mechanism and rotatable sheath.

7. The system of claim 1 , wherein the needle is curved.

8. The system of claim 1 , wherein the needle is straight.

9. The system of claim 1 , wherein the one or more anchors include at least one internal lumen protrusion and the distal end portion of the needle includes a corresponding mating feature to facilitate snap engagement of the one or more anchors with the distal end portion.

10. The system of claim 9 , wherein the at least one internal lumen protrusion includes two opposing internal lumen protrusions.

11. An implant system for treating a pelvic condition, comprising:

sling implant having a support portion and end tissue anchors;

a needle delivery device having a handle housing and a needle, wherein the needle includes a distal tip adapted for selective engagement with at least one of the end tissue anchors;

an elongate sheath having a proximal tip shrouded and rotatable within the handle housing, a distal tip, and adapted to at least partially shroud a length of the needle; and

an actuation mechanism shrouded within the handle housing and having an actuator in operable communication with the elongate sheath, and including a shaft adapted to traverse in and out of the handle housing, such that activation of the actuator operably rotates the sheath about the needle without moving the sheath distally, such that the distal tip of the elongate sheath rotatably abuts at least one of the end tissue anchors to facilitate deployment.

12. The system of claim 11 , wherein the end tissue anchors each include extending anchor tines.

13. The system of claim 12 , wherein the elongate sheath includes a barb guard adapted to abut against the extending anchor tines.

14. The system of claim 11 , wherein the elongate sheath includes an angled end surface adapted to engage with at least one of the end anchors such that rotation of the elongate sheath forces at least one of the end anchors from the distal tip of the needle.

15. The system of claim 11 , wherein the actuator is a pushable button in operable communication with the rotatable sheath.

16. The system of claim 11 , wherein the needle is curved.

17. The system of claim 11 , wherein the needle is straight.

18. The system of claim 11 , wherein at least one of the end anchors includes at least one internal lumen protrusion and the distal tip of the needle includes a corresponding mating feature to facilitate snap engagement of the at least one end anchor with the distal tip.

19. The system of claim 11 , further including a second needle delivery device adapted to engage with one of the end anchors.

20. The system of claim 11 , wherein the actuation mechanism further includes a cam mechanism adapted to operably facilitate the rotation of the rotatable sheath about the needle.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: ASTORA WOMEN'S HEALTH, LLC; ENDO HEALTH SOLUTIONS INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043778/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: BOSTON SCIENTIFIC CORPORATION
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 043780/0316 →
SECURITY INTEREST Recorded Jun 8, 2017
From: ASTORA WOMEN'S HEALTH, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0278 →
CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA; PREVIOUSLY RECORDED ON REEL 037300 FRAME 0199. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Feb 25, 2016
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 037916/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: AMS RESEARCH, LLC
To: APHRODITE WOMEN'S HEALTH, LLC
Reel/Frame 037473/0745 →
CHANGE OF NAME Recorded Jan 11, 2016
From: APHRODITE WOMEN'S HEALTH, LLC
To: ASTORA WOMEN'S HEALTH, LLC
Reel/Frame 037473/0919 →
CHANGE OF NAME Recorded Dec 15, 2015
From: AMS RESEARCH CORPATION
To: AMS RESEARCH, LLC
Reel/Frame 037300/0199 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →